Yahoo Japan will be selling a direct-to-consumer genetic testing kit beginning next month, reports MIT's Technology Review. The test, called GeneLife2012, costs ¥29,800 and evaluates variants linked to disease risk. Tech Review notes that Yahoo Japan will only handle the marketing and that Tokyo-based Genesis Health Care will conduct all testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.